A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Hlavní autor: | Shehab, Habibul Mohsin |
---|---|
Další autoři: | Yasmin, Hasina |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
Brac University
2024
|
Témata: | |
On-line přístup: | http://hdl.handle.net/10361/22683 |
Podobné jednotky
-
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
Autor: Tabassum, Nadira
Vydáno: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
Autor: Mahee, Sadique Abdal
Vydáno: (2024) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Autor: Alim, Abdul
Vydáno: (2023) -
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
Autor: Karmaker, Swastika
Vydáno: (2024) -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
Autor: Jahan, Nusrat
Vydáno: (2023)